Chief Operating Officer
Priya Mande has over 25 years’ experience in the pharmaceutical and biotech sector, 12 of which were at Glaxo Wellcome and GlaxoSmithKline where she was most recently senior Director of R&D Business Projects.
She has held a variety of roles across research, development, project management, finance and business strategy & operations. She was previously at PowderMed responsible for delivery of the vaccine immunotherapeutic portfolio. Priya was the Vaccine Research Project Leader for Influenza at Pfizer before becoming Chief Operating Officer of Hybrid BioSystems in 2009. Priya studied Applied Biochemistry at Brunel University, has a Diploma in Company Direction from the Institute of Directors and received her MBA with distinction from the London Business School.